April 15, 2025 - 14:20

HOUSTON, April 15, 2025 — KBR has secured a significant contract with Hanwha Impact Corporation to implement its ammonia cracking technology at a new clean power generation facility in Korea. This marks the second collaboration between the two companies, highlighting KBR's expertise in hydrogen production.
As part of this agreement, KBR will supply technology licensing, proprietary engineering design, and essential equipment and services for a facility capable of producing 214 metric tons of hydrogen per day. The project will leverage KBR’s innovative H2ACT® ammonia cracking technology, which is designed to efficiently convert ammonia into hydrogen, thereby supporting the transition to cleaner energy sources.
This initiative aligns with global efforts to reduce carbon emissions and promote sustainable energy solutions. The partnership underscores the growing importance of hydrogen as a clean fuel alternative and KBR's commitment to advancing technologies that facilitate the production of green hydrogen on a large scale.
July 14, 2026 - 19:52
NSF Funds 12 New Regional Innovation Engines Including Quantum Technologies InitiativeThe National Science Foundation has awarded funding for 12 new Regional Innovation Engines, a program designed to boost research, strengthen ties between academia and industry, and drive economic...
July 14, 2026 - 04:23
Santa Maria-Bonita seeks parent feedback on student technology useThe Santa Maria-Bonita School District is reaching out to parents and guardians for their input on how students use technology, with a districtwide survey set to close on Friday, July 17. The...
July 13, 2026 - 20:47
Zohran Mamdani Launches New Tech Teams to Help New YorkersNew York City mayoral candidate Zohran Mamdani announced on Monday the launch of what he calls Public Interest Technology Crews, or PIT Crews. The democratic socialist state assembly member framed...
July 13, 2026 - 07:17
Why Drug Discovery Needs Human-Relevant ModelsFor decades, drug discovery has leaned heavily on animal models to predict how new treatments will behave in humans. But the results have been mixed at best. A compound that cures disease in mice...